Skip to content

LBRX LBRX Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Alkermes logo
AlkermesALKS
$78.25M-5.0%
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
$5.26M
Alto Neuroscience logo
Alto NeuroscienceANRO
$4.06M-16.2%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
13.1%-163,599,987pp
Opko Health logo
Opko HealthOPK
$45.8M-4.2%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$46.27M-8.6%

Other financials

Income statement

See full
Net income-$19.1M-259%
EPS (diluted)-$0.67+95.5%

Balance sheet

See full
Cash & equivalents$320.7M
Total debt$3.5M
Total equity$378.7M+481%
Total assets$393.5M

Cash flow

See full
Operating cash flow-$23.3M-187%
CapEx$32.0K+52.4%
Free cash flow-$23.3M-186%

Valuation

See full
Market cap$874.06M+163%
Enterprise value$556.86M

Returns & leverage

See full
Return on equity-27.9%
Debt / equity
Current ratio35.7×

Where this comes from

Reported directly by LBRX in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LBRX's operating lease ROU assets?
LBRX (LBRX) reported operating lease ROU assets of $2.1M in Q1 2026.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.